188 related articles for article (PubMed ID: 6144503)
1. [Beta blockers in psychiatric disorders].
Rimón R; Ylitalo P
Duodecim; 1984; 100(7):402-10. PubMed ID: 6144503
[No Abstract] [Full Text] [Related]
2. [Balance-sheet after 5-years of beta-blocker use in psychiatry. General considerations on beta-active substances].
Scharbach H
Ann Med Psychol (Paris); 1977 Apr; 1(4):600-15. PubMed ID: 23717
[No Abstract] [Full Text] [Related]
3. [Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
Obukhov GA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):746-61. PubMed ID: 6115528
[No Abstract] [Full Text] [Related]
4. [Extension of therapeutic possibilities by a new tranquilizer].
Leube H
Arzneimittelforschung; 1968 Dec; 18(12):1566-8. PubMed ID: 5756250
[No Abstract] [Full Text] [Related]
5. Beta-blockers and the central nervous system.
Wink CA
S Afr Med J; 1976 Jul; 50(32):1260-2. PubMed ID: 9696
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric uses of beta-blockers.
Cuche H; Deniker P
Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):267-72. PubMed ID: 6108581
[TBL] [Abstract][Full Text] [Related]
7. The use of prescription drugs in treatment of first-time psychiatric admissions to University Hospital, Saskatoon.
Frey DD; Hetherington RW; Glassman D
Soc Sci Med (1967); 1978 May; 12(3A):169-74. PubMed ID: 675269
[No Abstract] [Full Text] [Related]
8. [Thoughts on 12 years use of thioridazine (with reference to 198 cases)].
Nachin C
Ann Med Psychol (Paris); 1973 Apr; 1(4):535-42. PubMed ID: 4732841
[No Abstract] [Full Text] [Related]
9. [The use of psychopharmacologic agents in certain indicated groups].
Scharfetter C
Med Klin; 1967 Jun; 62(22):861-3. PubMed ID: 4385893
[No Abstract] [Full Text] [Related]
10. [Beta-blockaders in psychiatry].
Korsgaard S; Skausig OB
Ugeskr Laeger; 1978 Oct; 140(42):2594-6. PubMed ID: 29370
[No Abstract] [Full Text] [Related]
11. [Therapy of neuro-psychiatric diseases with pyridin-beta-caronic acid (I)].
Berzewski H
Med Welt; 1971 Oct; 42():1657-61. PubMed ID: 5117324
[No Abstract] [Full Text] [Related]
12. [Beta blockers, calcium channel blockers and psyche].
Strandberg T; Viukari M
Duodecim; 1994; 110(4):397-402. PubMed ID: 7555829
[No Abstract] [Full Text] [Related]
13. [Indications for beta-receptor blockaders in psychiatry].
Benkert O
Internist (Berl); 1978 Sep; 19(9):542-6. PubMed ID: 29854
[No Abstract] [Full Text] [Related]
14. [Beta blockers in psychiatric diseases. Indications and problems].
Schubert H; Fleischhacker W
ZFA (Stuttgart); 1979 Jun; 55(16):978-82. PubMed ID: 37662
[No Abstract] [Full Text] [Related]
15. [The psychotropic properties of beta-adrenoblockers].
Arushanian EB; Beĭer EV
Eksp Klin Farmakol; 1994; 57(2):63-8. PubMed ID: 7911368
[No Abstract] [Full Text] [Related]
16. [Psychiatric indications for beta-adrenergic inhibitors].
Féline A; Peyre F
Therapie; 1985; 40(6):413-6. PubMed ID: 2868537
[No Abstract] [Full Text] [Related]
17. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
Haugen T
Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
[No Abstract] [Full Text] [Related]
18. Proceedings: Clinical effects of beta-adrenergic blockers in psychiatry.
Kabes J; Dostal T; Taussigová D; Kabesová L
Act Nerv Super (Praha); 1975; 17(4):279-80. PubMed ID: 3937
[No Abstract] [Full Text] [Related]
19. Beta blockers in psychiatric illness.
Drug Ther Bull; 1974 Jul; 12(14):54-5. PubMed ID: 4156514
[No Abstract] [Full Text] [Related]
20. [Medazepam. A new tranquilizer: simple test, intraindividual comparisons and combination therapy].
Spiegelberg U; Petrilowitsch N; Betz B
Arzneimittelforschung; 1968 Dec; 18(12):1559-63. PubMed ID: 5756249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
